HCAT
Price
$1.74
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Capitalization
130.95M
18 days until earnings call
Intraday BUY SELL Signals
SCDS
Price
$71.67
Change
-$0.16 (-0.22%)
Updated
Oct 22 closing price
Net Assets
9.13M
Intraday BUY SELL Signals
Interact to see
Advertisement

HCAT vs SCDS

HCAT vs SCDS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HCAT vs. SCDS commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCAT is a Hold and SCDS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HCAT with price predictions
Oct 22, 2026

HCAT sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for HCAT moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HCAT as a result. In 78 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

The Moving Average Convergence Divergence Histogram (MACD) for HCAT turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 42 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

HCAT broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HCAT entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 64 cases where HCAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

HCAT moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HCAT crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Following a +1.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCAT advanced for three days, in 178 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.299) is normal, around the industry mean (3.981). P/E Ratio (-0.473) is within average values for comparable stocks, (13.628). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (0.429) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. HCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

A.I.Advisor
a Summary for SCDS with price predictions
Oct 22, 2026

SCDS in -2.00% downward trend, sliding for three consecutive days on October 14, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SCDS declined for three days, in 25 of 36 cases, the price declined further within the following month. The odds of a continued downward trend are 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCDS as a result. In 15 of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.

The Aroon Indicator for SCDS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SCDS's RSI Oscillator exited the oversold zone, 7 of 9 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for SCDS just turned positive on October 21, 2026. Looking at past instances where SCDS's MACD turned positive, the stock continued to rise in 14 of 18 cases over the following month. The odds of a continued upward trend are 78%.

Following a +1.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCDS advanced for three days, in 28 of 44 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

SCDS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

FUNDAMENTALS RATINGS
HCAT: Fundamental Ratings
HCAT
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HCATSCDS
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
48%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
58%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 17 days ago
73%
Bullish Trend 2 days ago
64%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 9 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
55%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (HCAT: $1.74)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HCAT’s FA Score shows that 1 FA rating(s) are green while .

  • HCAT’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HCAT’s TA Score shows that 4 TA indicator(s) are bullish.

  • HCAT’s TA Score: 4 bullish, 6 bearish.

Price Growth

HCAT (@Services to the Health Industry) experienced а 0.00% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.51%. For the same industry, the average monthly price growth was -3.63%, and the average quarterly price growth was +16.27%.

Reported Earning Dates

HCAT is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Services to the Health Industry (-1.51% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
HCAT
Daily Signal:
Gain/Loss:
SCDS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HCAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCAT has been loosely correlated with KVYO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCAT jumps, then KVYO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCAT
1D Price
Change %
HCAT100%
N/A
KVYO - HCAT
47%
Loosely correlated
+1.98%
EVCM - HCAT
46%
Loosely correlated
+0.22%
RDVT - HCAT
45%
Loosely correlated
-0.60%
CPAY - HCAT
43%
Loosely correlated
+1.83%
COIN - HCAT
43%
Loosely correlated
-4.51%
More

SCDS and

Correlation & Price change

A.I.dvisor tells us that SCDS and ADPT have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCDS and ADPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCDS
1D Price
Change %
SCDS100%
-0.23%
ADPT - SCDS
19%
Poorly correlated
-3.63%
HCAT - SCDS
18%
Poorly correlated
N/A
AIT - SCDS
17%
Poorly correlated
-5.75%
PLXS - SCDS
15%
Poorly correlated
-7.51%
PENG - SCDS
15%
Poorly correlated
-11.08%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BSVO28.730.25
+0.88%
EA Bridgeway Omni Small-Cap Value ETF (BSVO)
MUSE48.06N/A
N/A
TCW Multisector Credit Income ETF (MUSE)
IBND29.72-0.05
-0.17%
State Street SPDR Bloomberg International Corporate Bond ETF (IBND)
SEPZ46.11-0.48
-1.02%
TrueShares Structured Outcome September ETF (SEPZ)
LTL22.23-0.72
-3.14%
ProShares Ultra Communication Services (LTL)